![](/images/lcrn/thames-valley-and-south-midlands/research%20appointment%201200%20x375.png)
More than 75,000 take part in Thames Valley research
14 June 2021
More than 75,000 participants took part in studies supported by the NIHR Clinical Research Network Thames Valley and South Midlands last year, new figures show.
14 June 2021
More than 75,000 participants took part in studies supported by the NIHR Clinical Research Network Thames Valley and South Midlands last year, new figures show.
11 June 2021
Prof Belinda Lennox, clinical director for the NIHR Clinical Research Network Thames Valley and South Midlands, will be stepping down at the end of September after seven years in post.
09 June 2021
Anti-inflammatory drug aspirin does not improve survival for hospitalised COVID-19 patients, a study has found.
01 June 2021
The first COVID-19 vaccine study in the UK recruiting pregnant women has been launched in Oxford.
26 May 2021
Prof Andrew Protheroe will leave his role as co-clinical director for the NIHR Clinical Research Network Thames Valley and South Midlands (LCRN) next week to become the national director for GenesisCare.
25 May 2021
World-first COVID-19 vaccine booster study launches in Oxford
25 May 2021
96% develop antibodies against COVID-19 after one jab, study finds
20 May 2021
Health service leaders have thanked more than 16,000 participants who took part in nationally-prioritised COVID-19 studies in Thames Valley and South Midlands.
07 May 2021
Oxford’s Dan Brain is a Research Champion, where members of the public volunteer to spread the word about health and care research.
06 May 2021
Mel McAulay is a Research Champion, where members of the public volunteer to spread the word about health and care research.
19 April 2021
A commonly used asthma drug shorterns recovery time in COVID-19 patients at risk of more severe illness, a study has reported.
19 April 2021
People are invited to an online talk to learn about how health researchers and the public have been working together on COVID-19 studies in Thames Valley.
08 April 2021
A trial into supporting people with suspected COVID-19 to stay out of hospital has added its first antiviral drug.
29 March 2021
The majority of survivors who left hospital following COVID-19 did not fully recover five months after discharge and continued to experience negative impacts on their physical and mental health, as well as ability to work, a study has reported.
19 March 2021
In this article, staff at Berkshire Healthcare NHS Foundation Trust reflect on the role they played in support studies into COVID-19 vaccines.
12 March 2021
An online event about the latest research into the causes, treatment and monitoring of Crohn’s and Colitis will be held next month.
25 February 2021
COVID-19 infection in pregnancy is not associated with stillbirth or early neonatal death, according to a new study.
23 February 2021
The Pfizer-BioNTech COVID-19 vaccine provides high levels of protection, analysis of healthcare workers who had the jab found.
23 February 2021
Join healthcare specialists working in COVID-19 vaccine research in the South of England to learn what we know about COVID-19 vaccines so far and the role research can continue to play.
15 February 2021
A study is to launch into whether the University of Oxford’s COVID-19 vaccine can offer protection to children and young adults.
11 February 2021
Shamin Durrani is a Research Champion, where members of the public volunteer to spread the word about health and care research. She joined the role to be an ambassador for research in ethnic minority communities.
11 February 2021
Tocilizumab reduces the risk of death for hospitalised patients with severe COVID-19, NIHR-backed research has found.
04 February 2021
The world’s first COVID-19 vaccine study researching alternating doses and intervals of approved vaccines has opened in Oxford.
04 February 2021
Research nurse Annie Rose is to begin a doctorate in the healthcare experience of transgender and gender-diverse people.
29 January 2021
A COVID-19 vaccine is 89.3% effective at preventing the virus, including new variants, interim results show.